Latent rheumatic, thyroid and phospholipid autoimmunity in hospitalized patients with COVID-19

Rodríguez, 2020, Autoinflammatory and autoimmune conditions at the crossroad of COVID-19, J. Autoimmun., 114, 102506, 10.1016/j.jaut.2020.102506 Zhou, 2020, Clinical and autoimmune characteristics of severe and critical cases of COVID-19, Clin. Transl. Sci., 13, 1077, 10.1111/cts.12805 Bertin, 2020, Anticardiolipin IgG autoantibody level is an independent risk factor for COVID-19 severity, Arthritis Rheum., 72, 1953, 10.1002/art.41409 Schiaffino, 2020, Immunoserologic detection and diagnostic relevance of cross-reactive autoantibodies in coronavirus disease 2019 patients, J. Infect. Dis., 222, 1439, 10.1093/infdis/jiaa485 Borghi, 2020, Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome, Front. Immunol., 11, 2692, 10.3389/fimmu.2020.584241 Lerma, 2020, Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19), J. Transl. Autoimmun., 3, 100073, 10.1016/j.jtauto.2020.100073 Sacchi, 2021, SARS-CoV-2 infection as a trigger of autoimmune response, Clin. Transl. Sci. n/a, 10.1111/cts.12953 Pascolini, 2021, COVID-19 and immunological dysregulation: can autoantibodies be useful?, Clin. Transl. Sci., 10.1111/cts.12908 Gatto, 2020, Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases, Clin. Exp. Rheumatol., 38, 754 Vlachoyiannopoulos, 2020, Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19, Ann. Rheum. Dis., 79, 1661, 10.1136/annrheumdis-2020-218009 Amezcua-Guerra, 2020, Presence of antiphospholipid antibodies in COVID-19: case series study, Ann. Rheum. Dis. Pineton de Chambrun, 2020, High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability?, J. Intern. Med., 13126 Zuo, 2020, Prothrombotic antiphospholipid antibodies in COVID-19, MedRxiv Woodruff, 2020, Clinically identifiable autoreactivity is common in severe SARS-CoV-2 Infection, MedRxiv Bastard, 2020, Autoantibodies against type I IFNs in patients with life-threatening COVID-19, Science, 80–, 370 Casciola-Rosen, 2020, IgM autoantibodies recognizing ACE2 are associated with severe COVID-19, MedRxiv 2013 Wang, 2020, Diverse functional autoantibodies in patients with COVID-19, MedRxiv Prepr. Serv. Heal. Sci. Franco, 2015, Autoimmune thyroid disease in Colombian patients with systemic lupus erythematosus, Clin. Endocrinol., 83, 943, 10.1111/cen.12662 Pacheco, 2020, Antinuclear autoantibodies: discordance among four different assays, Ann. Rheum. Dis., 79, 10.1136/annrheumdis-2018-214693 Botello, 2020, Prevalence of latent and overt polyautoimmunity in autoimmune thyroid disease: a systematic review and meta-analysis, Clin. Endocrinol., 93, 375, 10.1111/cen.14304 Lebart, 1995 Arbuckle, 2003, Development of autoantibodies before the clinical onset of systemic lupus erythematosus, N. Engl. J. Med., 349, 1526, 10.1056/NEJMoa021933 Molano-González, 2019, Cluster analysis of autoimmune rheumatic diseases based on autoantibodies. New insights for polyautoimmunity, J. Autoimmun., 98, 10.1016/j.jaut.2018.11.002 James, 2019, Latent autoimmunity across disease-specific boundaries in at-risk first-degree relatives of SLE and RA patients, EBioMedicine, 42, 76, 10.1016/j.ebiom.2019.03.063 Anaya, 2019, Sjögren’s syndrome and autoimmune thyroid disease: two sides of the same coin, Clin. Rev. Allergy Immunol., 56, 362, 10.1007/s12016-018-8709-9 Sterne, 2020, Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19, J. Am. Med. Assoc., 324, 1330, 10.1001/jama.2020.17023 Velavan, 2020, Mild versus severe COVID-19: laboratory markers, Int. J. Infect. Dis., 95, 304, 10.1016/j.ijid.2020.04.061 Leisman, 2020, Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes, Lancet Respir. Med., 8, 1233, 10.1016/S2213-2600(20)30404-5 Ponti, 2020, Biomarkers associated with COVID-19 disease progression, Crit. Rev. Clin. Lab Sci., 57, 389, 10.1080/10408363.2020.1770685 Goel, 2020, The liver in COVID-19: prevalence, patterns, predictors, and impact on outcomes of liver test abnormalities, Eur. J. Gastroenterol. Hepatol. Publish Ah Zuniga, 2021, Autoimmunity to the lung protective phospholipid-binding protein annexin A2 predicts mortality among hospitalized COVID-19 patients, MedRxiv, 2020